This latter idea is consistent with the variations in ICN1 levels and activity observed in T-ALL cells in which the abundance of endogenous Vav1 was manipulated by either expressing or depleting TLX and Vav1. The gene discussed is VAV1; the disease is acute lymphoblastic leukemia.